Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents

Details for Australian Patent Application No. 2003215678 (hide)

Owner Schering Aktiengesellschaft

Inventors Schacke, Heike; Jaroch, Stefan; Berger, Markus; Lehmann, Manfred; Krolikiewicz, Konrad; Schottelius, Arndt; Rehwinkel, Hartmut; Schmees, Norbert; Skuballa, Werner

Agent Davies Collison Cave

Pub. Number AU-B-2003215678

PCT Number PCT/EP03/03298

PCT Pub. Number WO2003/082827

Priority 102 15 316.7 02.04.02 DE

Filing date 29 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 18 September 2008

International Classifications

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/5377 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 102 15 316.7 02.04.02 DE

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003215678

18 September 2008 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

18 September 2008 Application Accepted

  Published as AU-B-2003215678

22 January 2009 Standard Patent Sealed

9 February 2012 Alteration of Name

  The name of the patentee has been altered to Bayer Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215679-HAIR CONDITIONING COMPOSITIONS CONTAINING SILICONE BLEND

2003215677-N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES